Global prevalence of polypharmacy among the COVID-19 patients: a comprehensive systematic review and meta-analysis of observational studies.

Hooman GhasemiNiloofar DarvishiNader SalariAmin Hosseinian-FarHakimeh AkbariMasoud Mohammadi

Published in: Tropical medicine and health (2022)

Polypharmacy is seen in many patients with COVID-19. Since there is no definitive cure for COVID-19, the multiplicity of drugs used to treat this disease can affect the severity of the disease and its side effects as a result of drug interactions. This highlights the importance of controlling and managing prescription drugs for patients with COVID-19.

Keyphrases

sars cov
coronavirus disease
risk factors
squamous cell carcinoma
adverse drug
radiation therapy
locally advanced